← Back to list
Newsletter Vol. 1, No. 02
Act
immediately
Effective date
Not stated in the notice
Identified
Jun 20, 2026
Summary
New Jersey Medicaid has updated their manufacturer/labeler code list, adding 5 new pharmaceutical manufacturers (including Novo Nordisk and Basel Pharmaceuticals), removing 1 manufacturer (Laboratory A), and updating names for 3 existing manufacturers. These changes affect which drug manufacturers are reimbursable under New Jersey Medicaid.
Get alerts when payers change rules like this one
We check New Jersey Medicaid and other payers every day and email you when a change matches your specialty and state.
Get New Jersey Medicaid alertsPolicy Monitoring is free. No card required.
What to do
immediately · 4 steps
01Billing team should update pharmacy billing systems to reflect the new manufacturer/labeler codes for New Jersey Medicaid claims.
02Add codes 00169 (Novo Nordisk), 72578 (LPI Holdings/Lexis Laboratories), 72579 (Seatrace Company), 72580 (Baron Pharmaceuticals), and 72581 (Basel Pharmaceuticals).
03Remove code 72577 (Laboratory A) as it will not be reimbursable.
04Update manufacturer names for existing codes: Reid Rowell to Solvay Pharmaceuticals, Carter Wallace to Baker Cummins, and Leukine to Immunex.
Original notice
Newsletter Vol. 1, No. 02
njmmis.com · Always check the source before changing claims.
Related changes
See all New Jersey Medicaid changes →Newsletter Vol. 1, No. 03HighEffective Nov 1, 1993 · Provider NoticeNewsletter Vol. 1, No. 1LowNo effective date · Provider NoticeNewsletter Vol. 1, No. 04MediumNo effective date · Provider NoticeNewsletter Vol. 1, No. 05HighNo effective date · CodingBrowse every New Jersey Medicaid change in the policy list